Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-31 @ 4:55 PM
Study NCT ID:
NCT00811733
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2008-12-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-03-01
Start Date Type:
None
Primary Completion Date:
2011-06-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-02-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-12-18
First Submit QC Date:
None
Study First Post Date:
2008-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-02-09
Results First Submit QC Date:
None
Results First Post Date:
2012-04-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-28
Last Update Post Date:
2017-05-30
Last Update Post Date Type:
ACTUAL